Riskpilot← Back to searchSign inGet full accessNORDIC BIOTECH ADVISORS ApS
APSActiveCVR 26123925Strandvejen 125Other activities auxiliary to financial services, except insurance and pension funding · NACE 6619Est. 20012 employees
Revenue 2024
DKK 1,9M
-58% vs 2023
EBITDA margin
-42.2%
-144% vs 2023
Equity ratio
79.8%
Financial strength
Net profit 2024
DKK -573K
-140% vs 2023
| Revenue | DKK 1,9M | -58% |
| EBITDA | DKK -792K | -144% |
| Net profit | DKK -573K | -140% |
| Total assets | DKK 5,3M | +2% |
| Equity | DKK 4,3M | -12% |
| Employees | 2 | — |
Legal name
NORDIC BIOTECH ADVISORS ApS
CVR number
26123925
Legal form
Anpartsselskab
NACE code
6619 · Other activities auxiliary to financial services, except insurance and pension funding
Founded
29. juni 2001
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at virke som finansierings- og investeringsvirksomhed samt anden i forbindelse hermed beslægtet virksomhed.
Address
Strandvejen 125
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2.730 | 3.700 | 3.812 | 4.496 | 1.875 |
| Staff expenses | -2.963 | -2.695 | -2.520 | -2.681 | -2.667 |
| EBITDA | -233 | 1.005 | 1.292 | 1.815 | -792 |
| Depreciation & amort. | -109 | -38 | -23 | -6 | -0 |
| EBIT | -341 | 967 | 1.270 | 1.809 | -792 |
| Net financials | 7 | -4 | -25 | 23 | 58 |
| Profit before tax | -387 | 937 | 1.240 | 1.832 | -734 |
| Tax | -86 | 279 | 297 | 399 | -161 |
| Net profit | -301 | 657 | 943 | 1.433 | -573 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2.531 | 3.241 | 4.261 | 5.255 | 5.340 |
| Equity | 1.802 | 2.459 | 3.402 | 4.834 | 4.262 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 729 | 782 | 859 | 420 | 1.078 |
| Total debt | 729 | 782 | 859 | 420 | 1.078 |
EBITDA margin
-42.2%
This company
15.8%
Market median
-367% vs market
20202024
Equity ratio
79.8%
This company
38.2%
Market median
+109% vs market
20202024
Return on equity
-13.4%
This company
18.4%
Market median
-173% vs market
20202024
Net profit margin
-30.5%
This company
8.1%
Market median
-477% vs market
20202024
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20202024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FS Chief Executive Officer | Chief Executive Officer | 2010 |
| Former (4) | ||
CL Management | Management | 2001 – 2008 |
BL Audit | Audit | 2001 – 2008 |
CK Management | Management | 2001 – 2011 |
JL Management | Management | 2008 – 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2002 | |
| Board of Directors | 2011 | |
| Former (2) | ||
| Chairman | 2001 – 2003 | |
| Board of Directors | 2001 – 2003 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2001 | |
| Individual | 25–33.32% | 25–33.32% | 2001 | |
| Company | 25–33.32% | 25–33.32% | 2001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Holdingselskabet af 1 januar 2016 ApSTECH GROWTH INVEST ApS
NORDIC BIOTECH ADVISORS ApS (this company)Board members of NORDIC BIOTECH ADVISORS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cora Louise Madsen | Management | 0 companies |
| Benny Lynge Sørensen | Audit | 0 companies |
| Christian Karsten Hansen | Management | 0 companies |
| Jennifer Louise Prender | Management | 0 companies |
| Florian Schønharting | Chief Executive Officer | 0 companies |
| Erik Hoffmeyer | Chairman | 0 companies |
| Matthew Daniel Perry | Board of Directors | 0 companies |
| Jakob Mosegaard Larsen | Board of Directors | 0 companies |
| Lars Henrik Munch | Board of Directors | 0 companies |